Literature DB >> 23143769

Rare cancers in children - The EXPeRT Initiative: a report from the European Cooperative Study Group on Pediatric Rare Tumors.

G Bisogno1, A Ferrari, E Bien, I B Brecht, B Brennan, G Cecchetto, J Godzinski, D Orbach, Y Reguerre, T Stachowicz-Stencel, D T Schneider.   

Abstract

The low incidence and the heterogeneity of very rare tumors (VRTs) demand for international cooperation. In 2008, EXPeRT (European Cooperative Study Group for Pediatric Rare Tumors) was founded by national groups from Italy, France, United Kingdom, Poland and Germany. The first aims of EXPeRT were to agree on a uniform definition of VRTs and to develop the currently most relevant scientific questions. Current initiatives include international data exchange, retrospective and prospective studies of specific entities, and the development of harmonized and internationally recognized guidelines. Moreover, EXPeRT established a network for expert consultation to assist in clinical decision in VRTs. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 23143769     DOI: 10.1055/s-0032-1327608

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  4 in total

Review 1.  Rare Tumors in Children: Progress Through Collaboration.

Authors:  Alberto S Pappo; Wayne L Furman; Kris A Schultz; Andrea Ferrari; Lee Helman; Mark D Krailo
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

2.  Rare childhood cancers--an increasing entity requiring the need for global consensus and collaboration.

Authors:  Rishi S Kotecha; Ursula R Kees; Catherine H Cole; Nicholas G Gottardo
Journal:  Cancer Med       Date:  2015-02-09       Impact factor: 4.452

3.  Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE).

Authors:  Marie de Tersant; Lucile Généré; Claire Freyçon; Sophie Villebasse; Rachid Abbas; Anne Barlier; Damien Bodet; Nadège Corradini; Anne-Sophie Defachelles; Natacha Entz-Werle; Cyrielle Fouquet; Louise Galmiche; Virginie Gandemer; Brigitte Lacour; Ludovic Mansuy; Daniel Orbach; Claire Pluchart; Yves Réguerre; Charlotte Rigaud; Sabine Sarnacki; Nicolas Sirvent; Jean-Louis Stephan; Estelle Thebaud; Anne-Paule Gimenez-Roqueplo; Laurence Brugières
Journal:  J Endocr Soc       Date:  2020-04-03

4.  The impact of incomplete registration on survival rate of children with very rare tumors.

Authors:  Jelena Rascon; Lukas Salasevicius; Giedre Rutkauskiene; Ewa Bien; Ieva Vincerzevskiene
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.